Preoperative Predictors of Blood Component Transfusion in Living Donor Liver Transplantation

Overview

Journal Asian J Transfus Sci

Specialty Hematology

Date 2013 Sep 10

PMID 24014945

Citations 7

Authors

R N Makroo

Rimpreet Singh Walia

Sanjeev Aneja

Aakanksha Bhatia

Mohit Chowdhry

Affiliations

Soon will be listed here.

Abstract

Context: Extensive bleeding associated with liver transplantation is a major challenge faced by transplant surgeons, worldwide.

Aims: To evaluate the blood component consumption and determine preoperative factors that predict the same in living donor liver transplantation (LDLT).

Settings And Design: This prospective study was performed for a 1 year period, from March 2010 to February 2011.

Materials And Methods: Intra- and postoperative utilization of blood components in 152 patients undergoing LDLT was evaluated and preoperative patient parameters like age, gender, height, weight, disease etiology, hemoglobin (Hb), hematocrit (Hct), platelet count (Plt), total leukocyte count (TLC), activated partial thromboplastin time (aPTT), international normalized ratio (INR), serum bilirubin (T. bilirubin), total proteins (T. proteins), albumin to globulin ratio (A/G ratio), serum creatinine (S. creatinine), blood urea (B. urea), and serum electrolytes were assessed to determine their predictive values. Univariate and stepwise discriminant analysis identified those factors, which could predict the consumption of each blood component.

Results: The average utilization of packed red cells (PRCs), cryoprecipitates (cryo), apheresis platelets, and fresh frozen plasma was 8.48 units, 2.19 units, 0.93 units, and 2,025 ml, respectively. Disease etiology and blood component consumption were significantly correlated. Separate prediction models which could predict consumption of each blood component in intra and postoperative phase of LDLT were derived from among the preoperative Hb, Hct, model for end-stage liver disease (MELD) score, body surface area (BSA), Plt, T. proteins, S. creatinine, B. urea, INR, and serum sodium and chloride.

Conclusions: Preoperative variables can effectively predict the blood component requirements during liver transplantation, thereby allowing blood transfusion services in being better prepared for surgical procedure.

Citing Articles

Safety assessment of RhD-positive red cell transfusion in RhD-negative liver-transplant recipients: Single-centre report from India.

Tiwari A, Arora D, Aggarwal G, Dara R, Bhardwaj G, Sharma J Indian J Med Res. 2021; 152(6):662-666.

PMID: 34145107 PMC: 8224149. DOI: 10.4103/ijmr.IJMR_315_19.

Perioperative blood transfusion decreases long-term survival in pediatric living donor liver transplantation.

Gordon K, Figueira E, Rocha-Filho J, Mondadori L, Giroud Joaquim E, Seda-Neto J World J Gastroenterol. 2021; 27(12):1161-1181.

PMID: 33828392 PMC: 8006094. DOI: 10.3748/wjg.v27.i12.1161.

Quality Improvement in Transfusion Practice of Orthotopic Liver Transplantation Reduces Blood Utilization, Length of Hospital Stay, and Cost.

Nedelcu E, Wright M, Karp S, Cook M, Barbu O, Eichbaum Q Am J Clin Pathol. 2018; 151(4):395-402.

PMID: 30535323 PMC: 6593127. DOI: 10.1093/ajcp/aqy154.

Blood Product Transfusion in Liver Transplantation and its Impact on Short-term Survival.

Kasraian L, Nikeghbalian S, Karimi M Int J Organ Transplant Med. 2018; 9(3):105-111.

PMID: 30487957 PMC: 6252178.

Established and potential predictors of blood loss during lung transplant surgery.

Oechslin P, Zalunardo M, Inci I, Schlaepfer M, Grande B J Thorac Dis. 2018; 10(6):3845-3848.

PMID: 30069385 PMC: 6051840. DOI: 10.21037/jtd.2018.05.165.

References

Cacciarelli T, Keeffe E, Moore D, Burns W, Busque S, Concepcion W . Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. Arch Surg. 1999; 134(1):25-9. DOI: 10.1001/archsurg.134.1.25. View

Nardo B, Bertelli R, Montalti R, Beltempo P, Puviani L, Pacile V . Red blood cell transfusion in liver transplantation: a case-control study. Transplant Proc. 2006; 37(10):4389-92. DOI: 10.1016/j.transproceed.2005.11.030. View

Snively C, Gutierrez C . Chronic kidney disease: prevention and treatment of common complications. Am Fam Physician. 2004; 70(10):1921-8. View

Lisman T, Leebeek F . Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg. 2007; 24(4):250-8. DOI: 10.1159/000103655. View

Steib A, Freys G, Lehmann C, Meyer C, Mahoudeau G . Intraoperative blood losses and transfusion requirements during adult liver transplantation remain difficult to predict. Can J Anaesth. 2001; 48(11):1075-9. DOI: 10.1007/BF03020372. View

Deakin M, Gunson B, Dunn J, McMaster P, Tisone G, Warwick J . Factors influencing blood transfusion during adult liver transplantation. Ann R Coll Surg Engl. 1993; 75(5):339-44. PMC: 2497978. View

Massicotte L, Beaulieu D, Thibeault L, Roy J, Marleau D, Lapointe R . Coagulation defects do not predict blood product requirements during liver transplantation. Transplantation. 2008; 85(7):956-62. DOI: 10.1097/TP.0b013e318168fcd4. View

Hendriks H, van der Meer J, Klompmaker I, Choudhury N, Hagenaars J, Porte R . Blood loss in orthotopic liver transplantation: a retrospective analysis of transfusion requirements and the effects of autotransfusion of cell saver blood in 164 consecutive patients. Blood Coagul Fibrinolysis. 2000; 11 Suppl 1:S87-93. DOI: 10.1097/00001721-200004001-00017. View

Porte R, Knot E, Bontempo F . Hemostasis in liver transplantation. Gastroenterology. 1989; 97(2):488-501. DOI: 10.1016/0016-5085(89)90090-5. View

10.

Modanlou K, Oliver D, Grossman B . Liver donor's age and recipient's serum creatinine predict blood component use during liver transplantation. Transfusion. 2009; 49(12):2645-51. DOI: 10.1111/j.1537-2995.2009.02325.x. View

11.

Noris M, Remuzzi G . Uremic bleeding: closing the circle after 30 years of controversies?. Blood. 1999; 94(8):2569-74. View

12.

Gonzalez-Casas R, Jones E, Moreno-Otero R . Spectrum of anemia associated with chronic liver disease. World J Gastroenterol. 2009; 15(37):4653-8. PMC: 2754513. DOI: 10.3748/wjg.15.4653. View

13.

Dalmau A, Sabate A, Acosta F, Garcia-Huete L, Koo M, Sansano T . Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation. Anesth Analg. 2000; 91(1):29-34. DOI: 10.1097/00000539-200007000-00006. View

14.

Floden A, Castedal M, Friman S, Olausson M, Backman L . Calculation and comparison of the model for end-stage liver disease (MELD) score in patients accepted for liver transplantation in 1999 and 2004. Transplant Proc. 2007; 39(2):385-6. DOI: 10.1016/j.transproceed.2007.01.013. View

15.

Mangus R, Kinsella S, Nobari M, Fridell J, Vianna R, Ward E . Predictors of blood product use in orthotopic liver transplantation using the piggyback hepatectomy technique. Transplant Proc. 2007; 39(10):3207-13. DOI: 10.1016/j.transproceed.2007.09.029. View

16.

McHutchison J, Manns M, Longo D . Definition and management of anemia in patients infected with hepatitis C virus. Liver Int. 2006; 26(4):389-98. DOI: 10.1111/j.1478-3231.2006.01228.x. View

17.

Alkozai E, Lisman T, Porte R . Bleeding in liver surgery: prevention and treatment. Clin Liver Dis. 2009; 13(1):145-154. DOI: 10.1016/j.cld.2008.09.012. View

18.

Chen H, Merchant N, Didolkar M . Hepatic resection using intermittent vascular inflow occlusion and low central venous pressure anesthesia improves morbidity and mortality. J Gastrointest Surg. 2000; 4(2):162-7. DOI: 10.1016/s1091-255x(00)80052-9. View

19.

Feng Z, Jin X, Chen Y . [Predictors of massive blood transfusion in liver transplantation for patients with benign end-stage liver disease]. Zhonghua Yi Xue Za Zhi. 2009; 88(43):3040-4. View

20.

Matthews J, Pagani F, Haft J, Koelling T, Naftel D, Aaronson K . Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality. Circulation. 2010; 121(2):214-20. PMC: 2824259. DOI: 10.1161/CIRCULATIONAHA.108.838656. View